230 related articles for article (PubMed ID: 16357159)
41. Antiangiogenic and antiproliferative effects of substituted-1,3,4-oxadiazole derivatives is mediated by down regulation of VEGF and inhibition of translocation of HIF-1alpha in Ehrlich ascites tumor cells.
Kumar A; D'Souza SS; Nagaraj SR; Gaonkar SL; Salimath BP; Rai KM
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1221-33. PubMed ID: 19370348
[TBL] [Abstract][Full Text] [Related]
42. Role of the host microenvironment on the expression of VEGF-subtypes in squamous cell carcinoma.
Brieger J; Vlachtsis K; Gieringer R; Mann W
Oncol Rep; 2003; 10(5):1503-6. PubMed ID: 12883731
[TBL] [Abstract][Full Text] [Related]
43. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
[TBL] [Abstract][Full Text] [Related]
44. Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma.
Lee TK; Poon RT; Yuen AP; Ling MT; Wang XH; Wong YC; Guan XY; Man K; Tang ZY; Fan ST
Clin Cancer Res; 2006 Dec; 12(23):6910-9. PubMed ID: 17145808
[TBL] [Abstract][Full Text] [Related]
45. Constitutive NF-kappaB activity regulates the expression of VEGF and IL-8 and tumor angiogenesis of human glioblastoma.
Xie TX; Xia Z; Zhang N; Gong W; Huang S
Oncol Rep; 2010 Mar; 23(3):725-32. PubMed ID: 20127012
[TBL] [Abstract][Full Text] [Related]
46. Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference.
Wang J; Shi YQ; Yi J; Ye S; Wang LM; Xu YP; He M; Kong XM
J Dig Dis; 2008 Nov; 9(4):228-37. PubMed ID: 18959596
[TBL] [Abstract][Full Text] [Related]
47. Angioarrestin: an antiangiogenic protein with tumor-inhibiting properties.
Dhanabal M; LaRochelle WJ; Jeffers M; Herrmann J; Rastelli L; McDonald WF; Chillakuru RA; Yang M; Boldog FL; Padigaru M; McQueeney KD; Wu F; Minskoff SA; Shimkets RA; Lichenstein HS
Cancer Res; 2002 Jul; 62(13):3834-41. PubMed ID: 12097297
[TBL] [Abstract][Full Text] [Related]
48. Analysis of angiogenesis induced by cultured corneal and oral mucosal epithelial cell sheets in vitro.
Kanayama S; Nishida K; Yamato M; Hayashi R; Sugiyama H; Soma T; Maeda N; Okano T; Tano Y
Exp Eye Res; 2007 Dec; 85(6):772-81. PubMed ID: 17904552
[TBL] [Abstract][Full Text] [Related]
49. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
Jung MH; Lee SH; Ahn EM; Lee YM
Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
[TBL] [Abstract][Full Text] [Related]
50. N-myc oncogene overexpression down-regulates IL-6; evidence that IL-6 inhibits angiogenesis and suppresses neuroblastoma tumor growth.
Hatzi E; Murphy C; Zoephel A; Rasmussen H; Morbidelli L; Ahorn H; Kunisada K; Tontsch U; Klenk M; Yamauchi-Takihara K; Ziche M; Rofstad EK; Schweigerer L; Fotsis T
Oncogene; 2002 May; 21(22):3552-61. PubMed ID: 12032857
[TBL] [Abstract][Full Text] [Related]
51. Tracking adult neovascularization during ischemia and inflammation using Vegfr2-LacZ reporter mice.
Heidenreich R; Murayama T; Silver M; Essl C; Asahara T; Rocken M; Breier G
J Vasc Res; 2008; 45(5):437-44. PubMed ID: 18418002
[TBL] [Abstract][Full Text] [Related]
52. Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L-ribose.
Uchimiya H; Furukawa T; Okamoto M; Nakajima Y; Matsushita S; Ikeda R; Gotanda T; Haraguchi M; Sumizawa T; Ono M; Kuwano M; Kanzaki T; Akiyama S
Cancer Res; 2002 May; 62(10):2834-9. PubMed ID: 12019161
[TBL] [Abstract][Full Text] [Related]
53. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
[TBL] [Abstract][Full Text] [Related]
54. Glucocorticoids suppress tumor angiogenesis and in vivo growth of prostate cancer cells.
Yano A; Fujii Y; Iwai A; Kageyama Y; Kihara K
Clin Cancer Res; 2006 May; 12(10):3003-9. PubMed ID: 16707595
[TBL] [Abstract][Full Text] [Related]
55. Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor associated with tumor cell proliferation in canine cutaneous squamous cell carcinomas and trichoepitheliomas.
Al-Dissi AN; Haines DM; Singh B; Kidney BA
Vet Pathol; 2007 Nov; 44(6):823-30. PubMed ID: 18039895
[TBL] [Abstract][Full Text] [Related]
56. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.
Zhang SX; Wang JJ; Gao G; Parke K; Ma JX
J Mol Endocrinol; 2006 Aug; 37(1):1-12. PubMed ID: 16901919
[TBL] [Abstract][Full Text] [Related]
57. S-1 inhibits tumorigenicity and angiogenesis of human oral squamous cell carcinoma cells by suppressing expression of phosphorylated Akt, vascular endothelial growth factor and fibroblast growth factor-2.
Harada K; Supriatno ; Kawashima Y; Yoshida H; Sato M
Int J Oncol; 2007 Feb; 30(2):365-74. PubMed ID: 17203218
[TBL] [Abstract][Full Text] [Related]
58. RUNX3 inhibits the expression of vascular endothelial growth factor and reduces the angiogenesis, growth, and metastasis of human gastric cancer.
Peng Z; Wei D; Wang L; Tang H; Zhang J; Le X; Jia Z; Li Q; Xie K
Clin Cancer Res; 2006 Nov; 12(21):6386-94. PubMed ID: 17085650
[TBL] [Abstract][Full Text] [Related]
59. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
Guo Y; Wang S; Hoot DR; Clinton SK
J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
[TBL] [Abstract][Full Text] [Related]
60. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
